Rehabilitation for long COVID and post-COVID interstitial lung disease: what do we know in 2025? - Amsterdam 2025

Long COVID 5 years on: where are we and where do we need to be?

Chair(s): Christopher E. Brightling, Rainer Gloeckl, Jamilah Meghji

Session type: Symposium

Rehabilitation for long COVID and post-COVID interstitial lung disease: what do we know in 2025?

Tessa Schneeberger

EVENTS HOME

Replay
Slides

Previous presentation

Next presentation

Session content

Mechanisms underlying long COVID: towards a personalised medicine approach for clinical care and trials

Rachael A. Evans

Replay

Slides

Post-COVID lung disease: prevalence, treatment and prognosis in 2025

Claudia Valenzuela

Replay

Slides

Rehabilitation for long COVID and post-COVID interstitial lung disease: what do we know in 2025?

Tessa Schneeberger

Replay

Slides

Definitions and patient-reported outcomes on long COVID 5 years on: defining the undefinable

Joan B Soriano

Replay

Slides

Discussion and Q&A

Replay

Session aims

to focus on long COVID 5 years after the COVID-19 pandemic started; to provide the latest insights into the underlying pathophysiology, respiratory sequelae such as post-COVID interstitial lung disease, therapeutic options including rehabilitation and healthcare models for people with long COVID; to provide a global perspective on future directions for research and clinical care of people living with long COVID.

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}